Mitochondrial translation deficiency impairs NAD+ -mediated lysosomal acidification.
Mikako YagiTakahiro ToshimaRie AmamotoYura DoHaruka HiraiDaiki SetoyamaDongchon KangTakeshi UchiumiPublished in: The EMBO journal (2021)
Mitochondrial translation dysfunction is associated with neurodegenerative and cardiovascular diseases. Cells eliminate defective mitochondria by the lysosomal machinery via autophagy. The relationship between mitochondrial translation and lysosomal function is unknown. In this study, mitochondrial translation-deficient hearts from p32-knockout mice were found to exhibit enlarged lysosomes containing lipofuscin, suggesting impaired lysosome and autolysosome function. These mice also displayed autophagic abnormalities, such as p62 accumulation and LC3 localization around broken mitochondria. The expression of genes encoding for nicotinamide adenine dinucleotide (NAD+ ) biosynthetic enzymes-Nmnat3 and Nampt-and NAD+ levels were decreased, suggesting that NAD+ is essential for maintaining lysosomal acidification. Conversely, nicotinamide mononucleotide (NMN) administration or Nmnat3 overexpression rescued lysosomal acidification. Nmnat3 gene expression is suppressed by HIF1α, a transcription factor that is stabilized by mitochondrial translation dysfunction, suggesting that HIF1α-Nmnat3-mediated NAD+ production is important for lysosomal function. The glycolytic enzymes GAPDH and PGK1 were found associated with lysosomal vesicles, and NAD+ was required for ATP production around lysosomal vesicles. Thus, we conclude that NAD+ content affected by mitochondrial dysfunction is essential for lysosomal maintenance.
Keyphrases
- oxidative stress
- gene expression
- transcription factor
- cell death
- cardiovascular disease
- induced apoptosis
- type diabetes
- coronary artery disease
- signaling pathway
- cell cycle arrest
- skeletal muscle
- reactive oxygen species
- insulin resistance
- endoplasmic reticulum
- dna binding
- fluorescent probe
- cardiovascular risk factors
- cardiovascular events